Treatment of blastomycosis with fluconazole: A pilot study

Clinical Infectious Diseases

Volumn 20, Issue 2, 1995, Pages 267-271

  Pappas, Peter G ^a,b,c,d,e   Bradsher, Robert W ^a,b,c,d,e   Chapman, Stanley W ^a,b,c,d,e   Kauffman, Carol A ^a,b,c,d,e   Dine, Alan ^a,b,c,d,e   Cloud, Gretchen A ^a,b,c,d,e   Dismukes, William E ^a,b,c,d,e  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e Roerig/Pfizer Corporation ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; BLASTOMYCOSIS; FEMALE; FLUCONAZOLE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0028801742     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/20.2.267     Document Type: Article

References (12)

1. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis and histoplasmosis with keto- conazole. Results of a prospective randomized clinical trial. Ann Intern Med 1985; 103:861-72.
2. Bradsher RW, Rice DC, Abernathy RS. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 1985; 103:872-9.
3. Dismukes WE, Bradsher RW Jr., Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 1992;93:489-97.
4. Lyman CA, Sugar AM, Diamond RD. Comparative activity of UK- 49,858 and amphotericin B against Blastomyces dermatitidis infections in mice. Antimicrob Agents Chemother 1986;29:161-2.
5. Galgiani JN. Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies. Rev Infect Dis 1990; 12(suppl):S272-5.
6. Grant SM, Clissold SP. Fluconazole: a review of its pharmacologic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990;39(6):877-916.
7. Stevens DA, Brummer E, McEwen JG, Perlman AM. Comparison of fluconazole and ketoconazole in experimental murine blastomycosis. Rev Infect Dis 1990; 12(suppl):S304-6.
8. Lockwood WR, Allison F Jr., Batson BE., Busey JF. The treatment of North American blastomycosis. Ten years experience. Am Rev Respir Dis 1969;100:314-20.
9. Busey JF. Blastomycosis. III. A comparative study of 2-hydroxystilba- midine and amphotericin B therapy. Am Rev Respir Dis 1972;105:812-8.
10. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12:308-29.
11. Taillan B, Ferrari E, Cosnefroy J Y, et al. Favourable outcome of blastomycosis of the brain stem with fluconazole and flucytosine treatment. Ann Med 1991;24:71-2.
12. Pearson GJ, Chin WF, Fong IW. Case report: treatment ofblastomyco- sis with fluconazole. Am J Med Sci 1992;303:313-5.